In patient samples, the authors suggest that production of small, immature IGFBP2+ adipocytes is negatively correlated with disease progression- suggesting that myeloma inhibits the formation of these cells, or that these cells are somehow utilized during MM progression (26). This evidence concerns the gene IGFBP2 and Miyoshi myopathy.